Bora Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.50 M
- Revenue Growth -12.73%
- Profit Growth 96.68%
- Ebitda 310.63%
- Net Worth -0.04%
- Total Assets 2.24%
About Bora Pharma
Bora Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 1995 and has a history of 29 years and four months. Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.50 M.
Ajay Bora and Atul Bora serve as directors at the Company.
Company Details
-
Location
Ahmed Nagar, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MH1995PTC093481
-
Company No.
093481
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Bora Pharma?
Board Members (2)
Financial Performance of Bora Pharma.
Bora Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.73% decrease. The company also saw a substantial improvement in profitability, with a 96.68% increase in profit. The company's net worth dipped by a decrease of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bora Pharma?
In 2021, Bora Pharma had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shri Anand Life Spaces LlpAjay Bora is a mutual person
Charges (Loans)
₹9.50 M
₹0
Charges Breakdown by Lending Institutions
- The Ahmednagar Merchants Co-Op Bank Ltd. : 0.40 Cr
- Others : 0.30 Cr
- The Ahmednagar Merchants Cooperative Bank Ltd : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Others | ₹0.50 M | Open |
| 29 Jan 2020 | Others | ₹2.50 M | Open |
| 22 Feb 2014 | The Ahmednagar Merchants Cooperative Bank Ltd | ₹0.50 M | Open |
| 16 Feb 2001 | The Ahmednagar Merchants Co-Op Bank Ltd. | ₹4.00 M | Open |
| 03 Feb 2000 | The Ahmednagar Merchants Cooperative Bank Ltd | ₹2.00 M | Open |
How Many Employees Work at Bora Pharma?
Bora Pharma has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bora Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bora Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.